Kazumi Shiosaki, Ph.D.
Managing Director, MPM Capital
Co-founder and CEO, Mitobridge
President, TwentyeightSeven
Co-founder and start-up CEO, Epizyme
Kazumi Shiosaki's Bio
Kazumi Shiosaki, Ph.D., is managing director of MPM Capital and co-founder, CEO and president of Mitobridge, Inc. She is the founder and CEO of Primera Diagnostics and Epizyme. Shiosaki was the former SVP of Drug Discovery for Millenium Pharmaceuticals, the president of Sideris Pharmaceuticals, Inc. and served as Scientific and Strategy Advisor at Galnea Corp. She is presently on the board of directors of ForteBio, Mitobridge and Sideris Pharmaceuticals.
